Bretazenil

Bretazenil (Cay-37274) is an analytical reference standard categorized as a GABAA receptor positive allosteric modulator. Bretazenil has anxiolytic-like effects in mice. It induces self-administration in rhesus monkeys but has a lower physical dependence liability in mice compared with benzodiazepines. This product is intended for analytical forensic applications. This product is also available as a general research tool (Cay-28411).Formal Name: 8-bromo-11,12,13,13aS-tetrahydro-9-oxo-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylic acid, 1,1-dimethylethyl ester. CAS Number: 84379-13-5. Molecular Formula: C19H20BrN3O3. Formula Weight: 418.3. Purity: >98%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 30 mg/ml, DMSO: 30 mg/ml, Ethanol: 20 mg/ml, PBS (pH 7.2): Partially soluble. lambdamax: 217 nm. SMILES: CC(C)(C)OC(C1=C2N(C=N1)C3=CC=CC(Br)=C3C(N4[C@@]2([H])CCC4)=O)=O. InChi Code: InChI=1S/C19H20BrN3O3/c1-19(2,3)26-18(25)15-16-13-8-5-9-22(13)17(24)14-11(20)6-4-7-12(14)23(16)10-21-15/h4,6-7,10,13H,5,8-9H2,1-3H3/t13-/m0/s1. InChi Key: LWUDDYHYYNNIQI-ZDUSSCGKSA-N.